Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site(legacy) | 80 |
| Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site(legacy) | 71 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site | 1 | 1 | 3 | 1 | 0 | 2 | 6 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 68 |
| China | 10 |
| Netherlands | 10 |
| Vietnam | 5 |
| Australia | 4 |
| France | 4 |
| Argentina | 1 |
| Ireland | 1 |
| Japan | 1 |
| Sweden | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 25 |
| Fairfield | 11 |
| Rotterdam | 8 |
| Hanoi | 5 |
| Kaleen | 3 |
| Zhengzhou | 3 |
| Amsterdam | 2 |
| Boardman | 2 |
| Cambridge | 2 |
| Beijing | 1 |